Please login to the form below

Not currently logged in
Email:
Password:

AbbVie's 'The Story of HS' wins at PMEA 2016

Takes top prize in Excellence in Training Capability Development
PMEA 2016

AbbVie picked up the prize for Excellence in Training Capability Development at the PMEA 2016 awards ceremony in London last week, seeing off competition from Novartis, Santen UK and Tillotts Pharma UK.

Supported by TVF Communications, AbbVie created 'The Story of HS: A Patient Journey' to provide educational information based on stakeholder needs.

The eLearning initiative encompasses life-before-illness, early disease signs and diagnosis through to medical consultation and the value of treatment with Humira (adalimumab).

The campaign joined the patient experience with the learning journey using video and interactive approaches and was shown to improve HS knowledge with healthcare professionals. The initiative has subsequently been requested for Humira's other indications.

PMEA's judges said: “'The Story of HS' took an innovative approach to training in a new therapy area.

“It was really refreshing to see the work incorporate research into the patient journey, bringing to life training in a disease area from the patient's perspective.

“With the addition of pre- and post-assessment, this was an excellent patient-centred approach to training compared to approaches normally taken.”

AbbVie also took home the award for Excellence in Physicians/Healthcare Provider Support Programmes for its 'PEER: Psoriasis Expert Exchange FoRum', created with support from Lucid.

The platform aimed to change clinical behaviour on a global scale to improve standards of care in the management of psoriatic arthritis, and has now reached over 4,000 physicians in 32 countries.

Commenting on the 'PEER' programme, the judges said it “stands out from the many support programmes already out there”.

They added: “AbbVie and Lucid really understood behaviour change and showed how this understanding could be applied for high impact.”

The PMEA programme, run by PMLiVE publisher PMGroup, is specifically designed to recognise and commend excellence in improving patient outcomes.

Article by
Rebecca Clifford

1st December 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...